Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia

Clinical trial NCT00497809 · COMPLETED

Trial details

NCT number: NCT00497809
Sponsor: AviGenics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Neutropenia

Start date: 2007-08-01
Primary completion: 2008-07-01
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.